Wendy DiCicco
Equibles does not estimate personal net worth.
About Wendy DiCicco
Earlier roles on record: CFO at Akari Therapeutics Plc (AKTX) until December 6, 2024. Akari Therapeutics Plc reported in an 8-K filed December 12, 2024 that Wendy DiCicco was terminated as Interim Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective December 6, 2024. The proxy statement of Akari Therapeutics Plc reports total compensation of $860,844 for Wendy DiCicco in fiscal 2024, including a base salary of $440,000. Disclosed compensation is on record for 2 fiscal years.
“On December 6, 2024, Wendy DiCicco’s consulting agreement was terminated and she is no longer serving as Interim Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of Akari Therapeutics, Plc (the “Company”) as of that date.”
Affiliation history
-
Start not stated–2024-12-06
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Akari Therapeutics Plc (AKTX) | Former Interim Chief Financial Officer | $440,000 | $860,844 |
| 2023 | Akari Therapeutics Plc (AKTX) | Former Interim Chief Financial Officer | $226,184 | $277,664 |